Hypothesis: Could Hepatitis B vaccine act as an immune adjuvant in glioblastoma? Clues to conduct further epidemiological analyses

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, Meric A.
dc.contributor.authorOzpinar, Aysel
dc.contributor.authorOzpinar, Alp
dc.contributor.authorHacker, Emily
dc.contributor.authorElmaci, Ilhan
dc.date.accessioned2025-10-16T15:21:39Z
dc.date.issued2020
dc.identifier.doi10.1016/j.intimp.2019.106038
dc.identifier.otherWOS:000527892200043
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7708
dc.publisherELSEVIER
dc.sourceINTERNATIONAL IMMUNOPHARMACOLOGY
dc.titleHypothesis: Could Hepatitis B vaccine act as an immune adjuvant in glioblastoma? Clues to conduct further epidemiological analyses
dc.typeReview

Dosyalar

Koleksiyonlar

WOS